Found: 19
Select item for more details and to access through your institution.
Letter: should we abandon FIB‐4 to characterise noninvasively patients with NAFLD? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 922, doi. 10.1111/apt.17448
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 817, doi. 10.1111/apt.17005
- Publication type:
- Article
Letter: dietitians are more than coaches.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 926, doi. 10.1111/apt.17446
- By:
- Publication type:
- Article
Editorial: deja vu all over again – let the P‐CAB wars begin. Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: risankizumab – ready to break ceilings? author's reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Meta‐analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 837, doi. 10.1111/apt.17433
- By:
- Publication type:
- Article
Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 918, doi. 10.1111/apt.17431
- By:
- Publication type:
- Article
Letter: Low to moderate alcohol intake and progression of non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 924, doi. 10.1111/apt.17429
- By:
- Publication type:
- Article
Letter: should we abandon FIB‐4 to characterise non‐invasively patients with NAFLD?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 920, doi. 10.1111/apt.17422
- By:
- Publication type:
- Article
Letter: be careful of gastrointestinal CMV infection in adverse events from ICIs therapy in solid tumours.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 916, doi. 10.1111/apt.17416
- By:
- Publication type:
- Article
Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 851, doi. 10.1111/apt.17414
- By:
- Publication type:
- Article
Editorial: Interdisciplinary and multidisciplinary approach to malnutrition in patients with inflammatory bowel disease.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: deja vu all over again—let the P‐CAB wars begin.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: risankizumab – ready to break ceilings?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 861, doi. 10.1111/apt.17399
- By:
- Publication type:
- Article
Impact of malnutrition and nutrition support in hospitalised patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 897, doi. 10.1111/apt.17389
- By:
- Publication type:
- Article
Meta‐analysis: The impact of light‐to‐moderate alcohol consumption on progressive non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 820, doi. 10.1111/apt.17388
- By:
- Publication type:
- Article
Potential benefit and lack of serious risk from corticosteroids in drug‐induced liver injury: An international, multicentre, propensity score‐matched analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 886, doi. 10.1111/apt.17373
- By:
- Publication type:
- Article
Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 872, doi. 10.1111/apt.17362
- By:
- Publication type:
- Article